Which therapy is considered hyperosmolar for intracranial pressure management?

• A. Hypertonic saline or mannitol
• B. Isotonic saline
• C. Dextrose solution
• D. Hypotonic saline

Answer: (A)

Hyperosmolar therapy lowers intracranial pressure by raising the osmolality of the blood. When you increase serum osmolality, water moves from swollen brain tissue into the intravascular space, shrinking the brain edema and thereby reducing ICP.

The two agents that achieve this effect are hypertonic saline and mannitol. Mannitol is an osmotic diuretic that stays in the vascular space to draw water out of the brain, while hypertonic saline raises plasma sodium and osmolality, also pulling water from brain tissue. Both are used in settings of cerebral edema when ICP is elevated, such as after traumatic brain injury, large strokes, or other causes of brain swelling.

By contrast, isotonic saline evenly expands the vascular compartment without creating a strong osmotic gradient to pull water from brain tissue, so it doesn’t directly lower ICP. Dextrose-containing solutions can transiently raise serum osmolality but glucose is metabolized and can lead to hyperglycemia and osmotic shifts that don’t provide sustained ICP relief, and hypotonic solutions can worsen cerebral edema by drawing water into the brain.

In short, the hyperosmolar approach for ICP management is achieved with hypertonic saline or mannitol, which create an osmotic gradient that reduces brain water content and lowers intracranial pressure.